QUANTIPORT, INC.

Portland, OR · Medtech · Defunct

Optical fiber probe device that measures blood volume by injecting a tracer and calculating dilution/elimination rate via reflectance spectroscopy

Grants
$330K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$98K
1 award · Defense
#527 of 4531 in medtech
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Defense · Phase I · Development of a Rapid and Accurate Blood Volume Analyzer for Combat Casualty Care$98,363
Federal contractDepartment of Defense · Award Of Quantiport, Inc.'s Army 2018.2 SBIR Phase I Medical R&d Contract From Proposal A182-122-0210 For Usaisr For "development Of A Rapid And Accurate Blood Volume Analyzer For Combat Casualty Care"$98,363
Federal grantDepartment of Health and Human Services · Phase I · Development of a rapid, scalable, and deployable point-of-care blood volume diagnostic for monitoring postpartum and trauma-related hemorrhage$231,308
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
524PROFUSA, INC.$100K$59M
525Surfplasma, Inc.$100K—
526Ionica Sciences, Inc$100K—
527QUANTIPORT, INC.$98K—
528CenTrak, Inc.$98K$832K
529HIGHLAND INSTRUMENTS INC$98K$750K
530New View Surgical, Inc.$98K$16M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Using Contrast-ultrasound To Quantify Total Circulating Blood Volumeapplication
  • Using Contrast-ultrasound To Quantify Total Circulating Blood Volumeapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.